 A very early stage of viral infection is viral entry, when the virus attaches to and enters the host cell.A number of "entry-inhibiting" or "entry-blocking" drugs are being developed to fight HIV.HIV most heavily targets the immune system's white blood cells known as "helper T cells", and identifies these target cells through T-cell surface receptors designated "CD4" and "CCR5".